(Q45479898)

English

A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

hepatitis E virus

object named as

hepatitis E virus

1 reference

based on heuristic

inferred from title

Suzanne U. Emerson

3

object named as

Suzanne U Emerson

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Robert H. Purcell

2

object named as

Robert H Purcell

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Yi-Hua Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

3157-3165

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis E virus superinfection in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Recombinant vaccines for hepatitis E.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Perspectives of vaccination against hepatitis E

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Animal models of hepatitis A and E.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Epidemic of hepatitis E in a military unit in Abbotrabad, Pakistan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Short report: phylogenetically distinct hepatitis E viruses in Pakistan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Recombinant subunit ORF2.1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.020

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.12.020

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45479898&oldid=2076976999"